Literature DB >> 10419891

T-cell receptor-independent activation of clonal Th2 cells associated with chronic hypereosinophilia.

F Roufosse1, L Schandené, C Sibille, B Kennes, A Efira, E Cogan, M Goldman.   

Abstract

We recently observed a clonal expansion of CD3(-)CD4(+) T cells secreting Th2-type cytokines in patients presenting chronic hypereosinophilia. As clonal T cells isolated from such patients did not spontaneously secrete cytokines in vitro, we reasoned that costimulatory signals delivered by antigen-presenting cells might be required to induce their full activation. To address this question, we investigated in two such patients the responses of CD3(-)CD4(+) T cells to dendritic cells (DC). DC elicited proliferation and production of interleukin-5 (IL-5) and IL-13 by clonal cells from patient 1 and upregulated their expression of CD25 (IL-2R-alpha). These effects were abolished when blocking monoclonal antibodies (MoAbs) against IL-2R-alpha and IL-2 were added to cocultures, indicating critical involvement of an autocrine IL-2/IL-2R pathway. Cells from patient 2 were stimulated by DC to produce Th2 cytokines only when rIL-2 or rIL-15 was added to cocultures. In both patients, addition of inhibitory MoAbs against B7-1/B7-2 or CD2 to cocultures resulted in dramatic reduction of cytokine production and inhibited CD25 upregulation. Thus, TCR/CD3-independent activation of clonal Th2 cells by DC is an IL-2-dependent process, which requires signaling through CD2 and CD28.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10419891

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  8 in total

1.  New diagnostic tool for differentiation of idiopathic hypereosinophilic syndrome (HES) and secondary eosinophilic states.

Authors:  T Berki; M Dávid; B Bóné; H Losonczy; J Vass; P Németh
Journal:  Pathol Oncol Res       Date:  2001       Impact factor: 3.201

2.  Human CD4+CD3- innate-like T cells provide a source of TNF and lymphotoxin-αβ and are elevated in rheumatoid arthritis.

Authors:  Vasileios Bekiaris; John R Šedy; Maura Rossetti; Roberto Spreafico; Shilpi Sharma; Antje Rhode-Kurnow; Brian C Ware; Nini Huang; Matthew G Macauley; Paula S Norris; Salvatore Albani; Carl F Ware
Journal:  J Immunol       Date:  2013-09-27       Impact factor: 5.422

3.  Expression of T lymphocyte chemoattractants and activation markers in vernal keratoconjunctivitis.

Authors:  A M Abu El-Asrar; S Struyf; S A Al-Kharashi; L Missotten; J Van Damme; K Geboes
Journal:  Br J Ophthalmol       Date:  2002-10       Impact factor: 4.638

4.  T-cell abnormalities are present at high frequencies in patients with hypereosinophilic syndrome.

Authors:  Grzegorz Helbig; Agata Wieczorkiewicz; Joanna Dziaczkowska-Suszek; Miroslaw Majewski; Slawomira Kyrcz-Krzemien
Journal:  Haematologica       Date:  2009-09       Impact factor: 9.941

Review 5.  Lymphoproliferative disorders involving T helper effector cells with defective LAT signalosomes.

Authors:  Romain Roncagalli; Michael Mingueneau; Claude Grégoire; Christelle Langlet; Bernard Malissen; Marie Malissen
Journal:  Semin Immunopathol       Date:  2010-01-28       Impact factor: 9.623

Review 6.  Hypereosinophilic syndromes.

Authors:  Florence E Roufosse; Michel Goldman; Elie Cogan
Journal:  Orphanet J Rare Dis       Date:  2007-09-11       Impact factor: 4.123

7.  Eosinophils affect functions of in vitro-activated human CD3-CD4+ T cells.

Authors:  Issam Harfi; Liliane Schandené; Sarah Dremier; Florence Roufosse
Journal:  J Transl Med       Date:  2013-05-06       Impact factor: 5.531

Review 8.  Gene Expression Comparison between Sézary Syndrome and Lymphocytic-Variant Hypereosinophilic Syndrome Refines Biomarkers for Sézary Syndrome.

Authors:  Andrea Moerman-Herzog; Syed J Mehdi; Henry K Wong
Journal:  Cells       Date:  2020-08-29       Impact factor: 6.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.